Does BEVACIZUMAB Cause Low density lipoprotein increased? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Low density lipoprotein increased have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.0% of all adverse event reports for BEVACIZUMAB.
15
Reports of Low density lipoprotein increased with BEVACIZUMAB
0.0%
of all BEVACIZUMAB reports
1
Deaths
12
Hospitalizations
How Dangerous Is Low density lipoprotein increased From BEVACIZUMAB?
Of the 15 reports, 1 (6.7%) resulted in death, 12 (80.0%) required hospitalization.
Is Low density lipoprotein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Low density lipoprotein increased?
EVOLOCUMAB (1,024)
INCLISIRAN (423)
ALIROCUMAB (336)
ROSUVASTATIN (241)
ATORVASTATIN (217)
EZETIMIBE (217)
LOMITAPIDE (164)
TOFACITINIB (135)
FINGOLIMOD (132)
SOMATROPIN (93)
Which BEVACIZUMAB Alternatives Have Lower Low density lipoprotein increased Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ